MX356867B - Espuma hemostatica. - Google Patents

Espuma hemostatica.

Info

Publication number
MX356867B
MX356867B MX2015007194A MX2015007194A MX356867B MX 356867 B MX356867 B MX 356867B MX 2015007194 A MX2015007194 A MX 2015007194A MX 2015007194 A MX2015007194 A MX 2015007194A MX 356867 B MX356867 B MX 356867B
Authority
MX
Mexico
Prior art keywords
foam
liquid foam
albumin
hemostatic liquid
foaming agent
Prior art date
Application number
MX2015007194A
Other languages
English (en)
Other versions
MX2015007194A (es
Inventor
Goessl Andreas
Gorna Katarzyna
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Publication of MX2015007194A publication Critical patent/MX2015007194A/es
Publication of MX356867B publication Critical patent/MX356867B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

La invención describe una preparación de base de espuma líquida hemostática farmacéutica que comprende albúmina como agente espumante y una sustancia precipitante de fibrinógeno y opcionalmente un agente de inducción de coagulación, en donde la albúmina como agente espumante está presente en forma nativa; un método para la producción de una espuma líquida hemostática transitoria; la espuma líquida hemostática transitoria; y un equipo o kit para hacer la espuma.
MX2015007194A 2012-12-07 2013-12-06 Espuma hemostatica. MX356867B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261734544P 2012-12-07 2012-12-07
PCT/EP2013/075852 WO2014086996A1 (en) 2012-12-07 2013-12-06 Hemostatic foam

Publications (2)

Publication Number Publication Date
MX2015007194A MX2015007194A (es) 2016-03-07
MX356867B true MX356867B (es) 2018-06-18

Family

ID=49725129

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007194A MX356867B (es) 2012-12-07 2013-12-06 Espuma hemostatica.

Country Status (15)

Country Link
US (2) US9168325B2 (es)
EP (1) EP2928511B1 (es)
JP (1) JP2016501255A (es)
KR (1) KR102199092B1 (es)
CN (1) CN104902935B (es)
AU (1) AU2013353931B2 (es)
BR (1) BR112015012985B8 (es)
CA (1) CA2893064C (es)
ES (1) ES2804534T3 (es)
HK (1) HK1212928A1 (es)
IL (1) IL238948A0 (es)
MX (1) MX356867B (es)
SG (1) SG11201504347RA (es)
WO (1) WO2014086996A1 (es)
ZA (1) ZA201503973B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
KR102068118B1 (ko) * 2011-10-28 2020-01-20 백스터 인터내셔널 인코포레이티드 뼈 지혈용 비-수성 조성물, 그의 사용 방법 및 제조 방법
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
BR112015012985B8 (pt) * 2012-12-07 2020-04-14 Baxter Healthcare Sa método para preparar uma espuma líquida hemostática farmacêutica, combinação de produto, espuma líquida hemostática farmacêutica transiente, kit para produzir uma espuma líquida hemostática farmacêutica transiente, e, uso de uma preparação farmacêutica
US10201690B2 (en) * 2013-06-19 2019-02-12 Robert Nutter Wound injector apparatus
BR112015030612B1 (pt) 2013-06-21 2020-07-21 Ferrosan Medical Devices A/S método para preparar uma composição seca
EP3470094B1 (en) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
US10283015B2 (en) 2015-04-08 2019-05-07 Biom'up Device and method for simulation of surface bleedings
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
IL247810A0 (en) 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Stable pharmaceutical foam
WO2018051325A1 (en) 2016-09-14 2018-03-22 Omrix Biopharmaceuticals Ltd. Stable pharmaceutical foam
US10980913B2 (en) 2018-03-05 2021-04-20 Ethicon Llc Sealant foam compositions for lung applications
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
DE102018009781A1 (de) 2018-12-13 2020-06-18 Valeopharm GmbH Verschäumbare wässrige Zubereitungen auf natürlicher Biopolymerbasis mit einsatzflexibler Gas(- vor allem Sauerstoffgas)-Speicherzellen-Verteilung
WO2021014356A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Foam compositions for wound treatment, systems of delivery, and methods of use
US11903961B2 (en) 2020-08-18 2024-02-20 Amrita Vishwa Vidyapeetham Hemostatic agent and method of production thereof
US20220241521A1 (en) * 2021-02-02 2022-08-04 Freedom Corp. Device for fibrin-biopolymer-forming substance application
AU2023232562A1 (en) 2022-03-08 2024-09-05 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system
WO2023177392A1 (en) * 2022-03-15 2023-09-21 Mayo Foundation For Medical Education And Research Tissue displacement foam

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6054122B2 (ja) * 1977-12-12 1985-11-28 日新製鋼株式会社 準安定オ−ステナイト系ステンレス鋼の冷間圧延方法
ATE13810T1 (de) * 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
JP2796558B2 (ja) 1986-04-01 1998-09-10 セイコーインスツルメンツ株式会社 液晶電気光学素子
US4892826A (en) * 1988-10-11 1990-01-09 Abbott Laboratories Process for the preparation of urokinase derivatives
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
FR2796558B1 (fr) 1999-07-21 2001-10-19 Imedex Biomateriaux Mousse adhesive a usage chirurgical et/ou therapeutique, et procede et kit pour son obtention
EP1115434B1 (fr) * 1999-07-21 2005-05-25 Imedex Biomateriaux Mousse proteique adhesive a usage chirurgical et/ou therapeutique
AU2001241644A1 (en) 2000-02-25 2001-09-03 David Sierra Foam-forming wound dressing
AU2002255220B2 (en) * 2001-01-25 2007-05-31 Topaz Investment As Carrier with solid fibrinogen and solid thrombin
US20030211137A1 (en) * 2001-02-21 2003-11-13 David Sierra Foam-forming wound dressing
US6703299B2 (en) 2001-12-21 2004-03-09 Intel Corporation Underfill process for flip-chip device
DK1973475T3 (da) 2006-01-17 2010-10-18 Baxter Int Blandeindretning, -system og -fremgangsmåde
ATE517645T1 (de) * 2006-03-01 2011-08-15 Fmc Biopolymer As Gelierte zusammensetzung
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US8512740B2 (en) 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
US8753670B2 (en) 2008-03-26 2014-06-17 Baxter International Inc. Fibrin foam and process
AU2009232000B2 (en) 2008-04-03 2014-12-11 Baxter International Inc. Hemostatic microspheres
CN102724968A (zh) * 2010-01-08 2012-10-10 普罗菲布瑞克斯公司 干粉血纤蛋白密封剂
CA2801116C (en) 2010-06-01 2019-02-12 Baxter International Inc. Process for making dry and stable hemostatic compositions
BR112015012985B8 (pt) * 2012-12-07 2020-04-14 Baxter Healthcare Sa método para preparar uma espuma líquida hemostática farmacêutica, combinação de produto, espuma líquida hemostática farmacêutica transiente, kit para produzir uma espuma líquida hemostática farmacêutica transiente, e, uso de uma preparação farmacêutica

Also Published As

Publication number Publication date
ES2804534T3 (es) 2021-02-08
CA2893064A1 (en) 2014-06-12
SG11201504347RA (en) 2015-07-30
BR112015012985B8 (pt) 2020-04-14
CN104902935B (zh) 2017-11-24
US10307509B2 (en) 2019-06-04
IL238948A0 (en) 2015-07-30
AU2013353931A1 (en) 2015-06-11
AU2013353931B2 (en) 2016-12-08
ZA201503973B (en) 2016-04-28
CA2893064C (en) 2021-05-04
EP2928511B1 (en) 2020-04-22
BR112015012985B1 (pt) 2020-03-17
KR102199092B1 (ko) 2021-01-07
US9168325B2 (en) 2015-10-27
US20150314037A1 (en) 2015-11-05
WO2014086996A1 (en) 2014-06-12
MX2015007194A (es) 2016-03-07
KR20150093198A (ko) 2015-08-17
HK1212928A1 (zh) 2016-06-24
US20140161738A1 (en) 2014-06-12
CN104902935A (zh) 2015-09-09
JP2016501255A (ja) 2016-01-18
EP2928511A1 (en) 2015-10-14

Similar Documents

Publication Publication Date Title
MX356867B (es) Espuma hemostatica.
PH12015501753A1 (en) Enhanced stability of novel liquid compositions
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
AU2013373885B2 (en) Oxazolidone compound, preparing method and application thereof
IN2015DN01165A (es)
IN2015DN01164A (es)
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MX356454B (es) Una formulacion enzimatica liquida y un proceso para su preparacion.
UA113448C2 (xx) Везикули, які містять епідермальний фактор росту і його композиції
MX2013004693A (es) Composiciones de aripiprazol y metodos para su suministro transdermico.
MY169064A (en) Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
EA201591047A1 (ru) Новая фармацевтическая композиция
PH12016501117A1 (en) Pharmaceutical compositions of carotenoid
MX2015005510A (es) Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
PH12014502261A1 (en) Therapeutic preparation and process for preparing the said therapeutic prepapration
WO2014184659A3 (en) Bubble encapsulation via silicilic acid complexation
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2014115087A3 (en) A method for the preparation of recombinant human prothrombin and fibrinogen
BR112015015476A8 (pt) uso de compostos químicos capazes de inibir a ação tóxica das esfingomielinases d do veneno de aranhas loxosceles e composição farmacêutica compreendendo os referidos compostos
WO2014199151A3 (en) Process of producing a fabric treatment agent and method of pre-treating a garment / fabric
ME03741B (me) Konpleksi agomelatina i sulfonskih kisjelina, postupak njihove proizvodnje i proizvodnje farmaceutskih pripravaka koji ih sadržavaju
GR1007770B (el) Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου
MY187672A (en) Pharmaceutical preparation for anaesthetic use and associated preparation process
CN302464751S (zh) 剪刀(Ref. 3781 KIDI'CUT)
TWD157287S (zh) 手工藝用針刺工具

Legal Events

Date Code Title Description
FG Grant or registration